July 12, 2019 / 5:34 AM / 3 months ago

BRIEF-Abivax Completes EUR 12 Million Capital Increase

July 12 (Reuters) - ABIVAX SA:

* COMPLETED ON THURSDAY A €12 MILLION CAPITAL RAISE ENTIRELY SUBSCRIBED BY SOFINNOVA PARTNERS AT MARKET PRICE

* ABIVAX CASH RUNWAY EXTENDED TO END OF Q2, 2020

* PROCEEDS TO BE USED FOR FUNDING ADVANCED STAGE CLINICAL TRIALS IN INFLAMMATION AND ONCOLOGY

* CAPITAL INCREASE OF 1,500,000 NEW ORDINARY SHARES WITH A NOMINAL VALUE OF €0.01 PER SHARE, ENTIRELY SUBSCRIBED BY SOFINNOVA CROSSOVER

Source text: bit.ly/2H46RHv

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below